Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1120399

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1120399

Global Gonorrhea Therapeutics Market Insights, Forecast to 2028

PUBLISHED:
PAGES: 108 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the Gonorrhea Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Monotherapy
    • 1.2.3 Dual Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gonorrhea Therapeutics Market Perspective (2017-2028)
  • 2.2 Gonorrhea Therapeutics Growth Trends by Region
    • 2.2.1 Gonorrhea Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Gonorrhea Therapeutics Historic Market Size by Region (2017-2022)
    • 2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Region (2023-2028)
  • 2.3 Gonorrhea Therapeutics Market Dynamics
    • 2.3.1 Gonorrhea Therapeutics Industry Trends
    • 2.3.2 Gonorrhea Therapeutics Market Drivers
    • 2.3.3 Gonorrhea Therapeutics Market Challenges
    • 2.3.4 Gonorrhea Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gonorrhea Therapeutics Players by Revenue
    • 3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2017-2022)
    • 3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
  • 3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
    • 3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2021
  • 3.5 Gonorrhea Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Gonorrhea Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Gonorrhea Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gonorrhea Therapeutics Breakdown Data by Type

  • 4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2017-2022)
  • 4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2023-2028)

5 Gonorrhea Therapeutics Breakdown Data by Application

  • 5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2017-2022)
  • 5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Gonorrhea Therapeutics Market Size (2017-2028)
  • 6.2 North America Gonorrhea Therapeutics Market Size by Type
    • 6.2.1 North America Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 6.2.2 North America Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 6.2.3 North America Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 6.3 North America Gonorrhea Therapeutics Market Size by Application
    • 6.3.1 North America Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 6.3.2 North America Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 6.3.3 North America Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 6.4 North America Gonorrhea Therapeutics Market Size by Country
    • 6.4.1 North America Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 6.4.2 North America Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gonorrhea Therapeutics Market Size (2017-2028)
  • 7.2 Europe Gonorrhea Therapeutics Market Size by Type
    • 7.2.1 Europe Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 7.2.2 Europe Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 7.2.3 Europe Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 7.3 Europe Gonorrhea Therapeutics Market Size by Application
    • 7.3.1 Europe Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 7.3.2 Europe Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 7.3.3 Europe Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 7.4 Europe Gonorrhea Therapeutics Market Size by Country
    • 7.4.1 Europe Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 7.4.2 Europe Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Gonorrhea Therapeutics Market Size (2017-2028)
  • 8.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Gonorrhea Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gonorrhea Therapeutics Market Size (2017-2028)
  • 9.2 Latin America Gonorrhea Therapeutics Market Size by Type
    • 9.2.1 Latin America Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 9.3 Latin America Gonorrhea Therapeutics Market Size by Application
    • 9.3.1 Latin America Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 9.4 Latin America Gonorrhea Therapeutics Market Size by Country
    • 9.4.1 Latin America Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gonorrhea Therapeutics Market Size (2017-2028)
  • 10.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Gonorrhea Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bharat Pharmaceuticals
    • 11.1.1 Bharat Pharmaceuticals Company Details
    • 11.1.2 Bharat Pharmaceuticals Business Overview
    • 11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
    • 11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.1.5 Bharat Pharmaceuticals Recent Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Company Details
    • 11.2.2 GlaxoSmithKline Business Overview
    • 11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
    • 11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.2.5 GlaxoSmithKline Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Company Details
    • 11.3.2 Merck Business Overview
    • 11.3.3 Merck Gonorrhea Therapeutics Introduction
    • 11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.3.5 Merck Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Gonorrhea Therapeutics Introduction
    • 11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.4.5 Pfizer Recent Developments
  • 11.5 Alopexx Pharmaceuticals
    • 11.5.1 Alopexx Pharmaceuticals Company Details
    • 11.5.2 Alopexx Pharmaceuticals Business Overview
    • 11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
    • 11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.5.5 Alopexx Pharmaceuticals Recent Developments
  • 11.6 AstraZeneca
    • 11.6.1 AstraZeneca Company Details
    • 11.6.2 AstraZeneca Business Overview
    • 11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
    • 11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.6.5 AstraZeneca Recent Developments
  • 11.7 Debiopharm Group
    • 11.7.1 Debiopharm Group Company Details
    • 11.7.2 Debiopharm Group Business Overview
    • 11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
    • 11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.7.5 Debiopharm Group Recent Developments
  • 11.8 Melinta Therapeutics
    • 11.8.1 Melinta Therapeutics Company Details
    • 11.8.2 Melinta Therapeutics Business Overview
    • 11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
    • 11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.8.5 Melinta Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Monotherapy
    • 1.2.3 Dual Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Clinics
    • 1.3.3 Hospitals
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gonorrhea Therapeutics Market Perspective (2017-2028)
  • 2.2 Gonorrhea Therapeutics Growth Trends by Region
    • 2.2.1 Gonorrhea Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Gonorrhea Therapeutics Historic Market Size by Region (2017-2022)
    • 2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Region (2023-2028)
  • 2.3 Gonorrhea Therapeutics Market Dynamics
    • 2.3.1 Gonorrhea Therapeutics Industry Trends
    • 2.3.2 Gonorrhea Therapeutics Market Drivers
    • 2.3.3 Gonorrhea Therapeutics Market Challenges
    • 2.3.4 Gonorrhea Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gonorrhea Therapeutics Players by Revenue
    • 3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2017-2022)
    • 3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
  • 3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
    • 3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2021
  • 3.5 Gonorrhea Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Gonorrhea Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Gonorrhea Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gonorrhea Therapeutics Breakdown Data by Type

  • 4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2017-2022)
  • 4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2023-2028)

5 Gonorrhea Therapeutics Breakdown Data by Application

  • 5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2017-2022)
  • 5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Gonorrhea Therapeutics Market Size (2017-2028)
  • 6.2 North America Gonorrhea Therapeutics Market Size by Type
    • 6.2.1 North America Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 6.2.2 North America Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 6.2.3 North America Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 6.3 North America Gonorrhea Therapeutics Market Size by Application
    • 6.3.1 North America Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 6.3.2 North America Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 6.3.3 North America Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 6.4 North America Gonorrhea Therapeutics Market Size by Country
    • 6.4.1 North America Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 6.4.2 North America Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gonorrhea Therapeutics Market Size (2017-2028)
  • 7.2 Europe Gonorrhea Therapeutics Market Size by Type
    • 7.2.1 Europe Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 7.2.2 Europe Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 7.2.3 Europe Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 7.3 Europe Gonorrhea Therapeutics Market Size by Application
    • 7.3.1 Europe Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 7.3.2 Europe Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 7.3.3 Europe Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 7.4 Europe Gonorrhea Therapeutics Market Size by Country
    • 7.4.1 Europe Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 7.4.2 Europe Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Gonorrhea Therapeutics Market Size (2017-2028)
  • 8.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Gonorrhea Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gonorrhea Therapeutics Market Size (2017-2028)
  • 9.2 Latin America Gonorrhea Therapeutics Market Size by Type
    • 9.2.1 Latin America Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 9.3 Latin America Gonorrhea Therapeutics Market Size by Application
    • 9.3.1 Latin America Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 9.4 Latin America Gonorrhea Therapeutics Market Size by Country
    • 9.4.1 Latin America Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gonorrhea Therapeutics Market Size (2017-2028)
  • 10.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Gonorrhea Therapeutics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Gonorrhea Therapeutics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Gonorrhea Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bharat Pharmaceuticals
    • 11.1.1 Bharat Pharmaceuticals Company Details
    • 11.1.2 Bharat Pharmaceuticals Business Overview
    • 11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
    • 11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.1.5 Bharat Pharmaceuticals Recent Developments
  • 11.2 GlaxoSmithKline
    • 11.2.1 GlaxoSmithKline Company Details
    • 11.2.2 GlaxoSmithKline Business Overview
    • 11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
    • 11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.2.5 GlaxoSmithKline Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Company Details
    • 11.3.2 Merck Business Overview
    • 11.3.3 Merck Gonorrhea Therapeutics Introduction
    • 11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.3.5 Merck Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Gonorrhea Therapeutics Introduction
    • 11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.4.5 Pfizer Recent Developments
  • 11.5 Alopexx Pharmaceuticals
    • 11.5.1 Alopexx Pharmaceuticals Company Details
    • 11.5.2 Alopexx Pharmaceuticals Business Overview
    • 11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
    • 11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.5.5 Alopexx Pharmaceuticals Recent Developments
  • 11.6 AstraZeneca
    • 11.6.1 AstraZeneca Company Details
    • 11.6.2 AstraZeneca Business Overview
    • 11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
    • 11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.6.5 AstraZeneca Recent Developments
  • 11.7 Debiopharm Group
    • 11.7.1 Debiopharm Group Company Details
    • 11.7.2 Debiopharm Group Business Overview
    • 11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
    • 11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.7.5 Debiopharm Group Recent Developments
  • 11.8 Melinta Therapeutics
    • 11.8.1 Melinta Therapeutics Company Details
    • 11.8.2 Melinta Therapeutics Business Overview
    • 11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
    • 11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2017-2022)
    • 11.8.5 Melinta Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer
  • Table 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Monotherapy
  • Table 3. Key Players of Dual Therapy
  • Table 4. Global Gonorrhea Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Gonorrhea Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Gonorrhea Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Gonorrhea Therapeutics Market Share by Region (2017-2022)
  • Table 8. Global Gonorrhea Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Gonorrhea Therapeutics Market Share by Region (2023-2028)
  • Table 10. Gonorrhea Therapeutics Market Trends
  • Table 11. Gonorrhea Therapeutics Market Drivers
  • Table 12. Gonorrhea Therapeutics Market Challenges
  • Table 13. Gonorrhea Therapeutics Market Restraints
  • Table 14. Global Gonorrhea Therapeutics Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Gonorrhea Therapeutics Revenue Share by Players (2017-2022)
  • Table 16. Global Top Gonorrhea Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2021)
  • Table 17. Ranking of Global Top Gonorrhea Therapeutics Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Gonorrhea Therapeutics Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Gonorrhea Therapeutics Product Solution and Service
  • Table 21. Date of Enter into Gonorrhea Therapeutics Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Gonorrhea Therapeutics Revenue Market Share by Type (2017-2022)
  • Table 25. Global Gonorrhea Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Gonorrhea Therapeutics Revenue Market Share by Type (2023-2028)
  • Table 27. Global Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Gonorrhea Therapeutics Revenue Share by Application (2017-2022)
  • Table 29. Global Gonorrhea Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Gonorrhea Therapeutics Revenue Share by Application (2023-2028)
  • Table 31. North America Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Gonorrhea Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Gonorrhea Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Gonorrhea Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Gonorrhea Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Gonorrhea Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Gonorrhea Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Gonorrhea Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Gonorrhea Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Gonorrhea Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Gonorrhea Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Gonorrhea Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Gonorrhea Therapeutics Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Gonorrhea Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Gonorrhea Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Gonorrhea Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Gonorrhea Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Gonorrhea Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Gonorrhea Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Gonorrhea Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Gonorrhea Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Gonorrhea Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Gonorrhea Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Bharat Pharmaceuticals Company Details
  • Table 62. Bharat Pharmaceuticals Business Overview
  • Table 63. Bharat Pharmaceuticals Gonorrhea Therapeutics Product
  • Table 64. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 65. Bharat Pharmaceuticals Recent Developments
  • Table 66. GlaxoSmithKline Company Details
  • Table 67. GlaxoSmithKline Business Overview
  • Table 68. GlaxoSmithKline Gonorrhea Therapeutics Product
  • Table 69. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 70. GlaxoSmithKline Recent Developments
  • Table 71. Merck Company Details
  • Table 72. Merck Business Overview
  • Table 73. Merck Gonorrhea Therapeutics Product
  • Table 74. Merck Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 75. Merck Recent Developments
  • Table 76. Pfizer Company Details
  • Table 77. Pfizer Business Overview
  • Table 78. Pfizer Gonorrhea Therapeutics Product
  • Table 79. Pfizer Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 80. Pfizer Recent Developments
  • Table 81. Alopexx Pharmaceuticals Company Details
  • Table 82. Alopexx Pharmaceuticals Business Overview
  • Table 83. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product
  • Table 84. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 85. Alopexx Pharmaceuticals Recent Developments
  • Table 86. AstraZeneca Company Details
  • Table 87. AstraZeneca Business Overview
  • Table 88. AstraZeneca Gonorrhea Therapeutics Product
  • Table 89. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 90. AstraZeneca Recent Developments
  • Table 91. Debiopharm Group Company Details
  • Table 92. Debiopharm Group Business Overview
  • Table 93. Debiopharm Group Gonorrhea Therapeutics Product
  • Table 94. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 95. Debiopharm Group Recent Developments
  • Table 96. Melinta Therapeutics Company Details
  • Table 97. Melinta Therapeutics Business Overview
  • Table 98. Melinta Therapeutics Gonorrhea Therapeutics Product
  • Table 99. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2017-2022) & (US$ Million)
  • Table 100. Melinta Therapeutics Recent Developments
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Gonorrhea Therapeutics Market Share by Type: 2021 VS 2028
  • Figure 2. Monotherapy Features
  • Figure 3. Dual Therapy Features
  • Figure 4. Global Gonorrhea Therapeutics Market Share by Application: 2021 VS 2028
  • Figure 5. Clinics Case Studies
  • Figure 6. Hospitals Case Studies
  • Figure 7. Others Case Studies
  • Figure 8. Gonorrhea Therapeutics Report Years Considered
  • Figure 9. Global Gonorrhea Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 10. Global Gonorrhea Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 11. Global Gonorrhea Therapeutics Market Share by Region: 2021 VS 2028
  • Figure 12. Global Gonorrhea Therapeutics Market Share by Players in 2021
  • Figure 13. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gonorrhea Therapeutics as of 2021)
  • Figure 14. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2021
  • Figure 15. North America Gonorrhea Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 16. North America Gonorrhea Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 17. North America Gonorrhea Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 18. North America Gonorrhea Therapeutics Market Size Share by Country (2017-2028)
  • Figure 19. United States Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Canada Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Europe Gonorrhea Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 22. Europe Gonorrhea Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 23. Europe Gonorrhea Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 24. Europe Gonorrhea Therapeutics Market Size Share by Country (2017-2028)
  • Figure 25. Germany Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. France Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. U.K. Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Italy Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Russia Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Nordic Countries Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific Gonorrhea Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 32. Asia Pacific Gonorrhea Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 33. Asia Pacific Gonorrhea Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 34. Asia Pacific Gonorrhea Therapeutics Market Size Share by Region (2017-2028)
  • Figure 35. China Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. India Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Australia Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 41. Latin America Gonorrhea Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 42. Latin America Gonorrhea Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 43. Latin America Gonorrhea Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 44. Latin America Gonorrhea Therapeutics Market Size Share by Country (2017-2028)
  • Figure 45. Mexico Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Brazil Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Middle East & Africa Gonorrhea Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 48. Middle East and Africa Gonorrhea Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 49. Middle East and Africa Gonorrhea Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 50. Middle East and Africa Gonorrhea Therapeutics Market Size Share by Country (2017-2028)
  • Figure 51. Turkey Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. Saudi Arabia Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. UAE Gonorrhea Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 55. GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 56. Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 57. Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 58. Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 59. AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 60. Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 61. Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2017-2022)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!